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A majority of endobronchial lesions are caused by
primary lung cancer. In some cases, however, the endo-
bronchial mass is, in fact, some other type of malignancy,
which may be only imitating lung cancer. Endobronchial
malignancies other than lung cancer may sometimes
develop in the course of hematologic disorders, such as
non-Hodgkin’s lymphoma, Hodgkin’s disease, plasmo-
cytoma, and chronic lymphocytic leukemia [1-4]. Pulmo-
nary Kaposi’s sarcoma may form the endobronchial mass.
This problem has gained importance in the era of the
AIDS epidemic and in view of the increasing number of
immunosuppressed patients after organ transplantation
[5, 6]. Extremely rare primary pulmonary melanoma
may occasionally manifest itself as an endobronchial
malignancy [7]. Occasionally, extrathoracic neoplasms
may metastasize into the bronchial wall creating
diagnostic difficulties [8]. The differential diagnosis of
these lesions from primary lung cancer is essential.
Lymphoma group of endobronchial lesions
N o n - H o d g k i n ’ s  l y m p h o m a
In case of non-Hodgkin’s lymphoma two patterns of
involvement of lower airways have been described: diffuse
submucosal infiltrates (occurring usually in the presence
of lymphoma signs in other intra- or extrathoracic sites)
and a mass obstructing the airway with or without the
signs of disseminated disease [9-11]. Primary non-
Hodgkin’s lymphoma develops in B-cells in mucosa-
associated lymphoid tissue [12]. Endobronchial masses
may be solitary or multiple: unilateral or bilateral [1, 9, 10,
12]. The bronchoscopic examination reveals a polypoid
tumor in the trachea and/or central or subsegmental
bronchi [1, 12, 13]. The bronchial obstruction may be
partial or complete and leading to atelectasis [1, 12].
Detailed radiographic studies, including computed
tomography (CT), may not reveal lymphadenopathy or
mediastinal involvement [12]. The cases of endobronchial
non-Hodgkin lymphoma are extremely rare, but they also
may be underestimated, and thus some authors suggest
that endoscopic studies should be performed in patients
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Primary or secondary malignancies other than lung cancer may develop endobronchially. Both the clinical picture and the
results of bronchoscopic examination may imitate primary lung cancer. Primary endobronchial malignancies may include
extremely rare forms of Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, plasmocytoma, chronic lymphocytic leukemia, as
well as Kaposi’s sarcoma (usually in immunosuppressed patients) and melanoma. Secondary (metastatic) endobronchial
lesions usually develop lately in the course of neoplastic disease and constitute about 1-2% of tumors developing in the
bronchial lumen. The most common endobronchial metastatic masses arise from such primary extrathoracic neoplasms, as
colon, rectal, breast, uterine, renal, head-neck carcinomas, melanoma, and osteosarcoma.
Wewnàtrzoskrzelowe zmiany nowotworowe inne ni˝ rak p∏uca
Do wewnàtrzoskrzelowych zmian nowotworowych, imitujàcych pierwotnego raka p∏uca, nale˝à niezwykle rzadkie postacie
nieziarniczego i ziarniczego ch∏oniaka, szpiczaka lub przewlek∏ej bia∏aczki limfatycznej, a tak˝e mi´sak Kaposi’ego (rozwijajàcy
si´ g∏ównie u osób w stanie immunosupresji) i czerniak.
Przerzuty wewnàtrzoskrzelowe guzów innych ni˝ rak p∏uca powstajà zwykle póêno w przebiegu choroby rozrostowej i stanowià
oko∏o 1-2% nowotworów stwierdzanych w Êwietle oskrzeli. Przerzuty wewnàtrzoskrzelowe wywodzà si´ najcz´Êciej z pierwotnego
raka jelita grubego, odbytnicy, piersi, nerki, macicy oraz okolicy g∏owy i szyi, a tak˝e z mi´saka koÊci lub czerniaka.
W diagnostyce ró˝nicowej guzów rozwijajàcych si´ wewnàtrzoskrzelowo nale˝y braç pod uwag´ rzadkie pierwotne lub wtórne
nowotwory, inne ni˝ drobnokomórkowy lub niedrobnokomórkowy rak p∏uca.
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with lymphoma and symptoms indicating bronchial
disease [14].
H o d g k i n ’ s  d i s e a s e
Endobronchial tumors may be found in 1,9% of cases of
Hodgkin’s disease [15]. They usually develop in the late
course of the disease and are rarely seen at presentation
[15]. In autopsy studies endobronchial lesions can be
found in 15% of cases [16]. Endobronchial Hodgkin’s
disease develops from mucosa-associated lymphoid tissue
[16]. The endobronchial masses which appear in the
course of Hodgkin’s disease cause coughing, wheezing
and hemoptysis [15]. They may present as intermittent
multilobar atelectases [2, 16]. Concomitant pneumo-
mediastinum has been described [16]. Mediastinal
(anterior and middle) involvement (with or without
disease in the hili) is common [2, 15, 16]. Clinically,
endobronchial Hodgkin’s disease can be confused with
small cell carcinoma [2]. Thus, it is important to include
Hodgkin’s disease in the differential diagnosis of
endobronchial masses, especially in relatively young
patients [16].
P l a s m o c y t o m a
Extramedullary plasmocytoma usually develops in the
upper respiratory tract, but in some cases may form
endobronchial masses [3]. Primary endobronchial plasmo-
cytoma is a very rare disease [17]. Endobronchial lesions
may occur as solitary plasmocytoma of the lung [18] or in
the course of multiple extramedullary plasmocytoma
confined to the lung [3]. Endobronchial lesions in the
course of extramedullary plasmocytoma may be unilateral
or bilateral [3, 17]. Severely hemorrhagic endobronchial
tumors have been described in the course of extra-
medullary plasmocytoma [3]. The occurrence of multiple
extramedullary plasmocytoma confined to the respiratory
system may be caused by an endobronchial metastatic
process or by a multicentric autochthonous process [3].
In the case of solitary plasmocytoma of the lung
histopathological studies of the tumor reveal sheets of
well-differentiated plasma cells and large extracellular
deposits of amorphous Congo red negative material [18].
Immunohistochemical studies of biopsy specimens may
reveal monoclonal kappa chains [17].
Solitary extramedullary plasmocytoma may develop
in the absence of abnormal proteinuria, with no mono-
clonal spike in the serum electrophoresis, with no plasma-
cytosis in the bone marrow biopsy specimen, and with no
other signs of multiple myeloma [18, 19]. In the case of
multiple extramedullary plasmocytoma Bence-Jones
proteins in the urine and IgA (kappa) components in the
serum may be present [3].
The best treatment for endobronchial plasmocytoma
has not been established. Long-term survival has been
observed in the case of primary endobronchial plasmo-
cytoma after complete surgical resection [17]. In the case
of extramedullary plasmocytoma laser treatment of
endobronchial lesions can be performed [19].
C h r o n i c  l y m p h o c y t i c  l e u k e m i a
Pulmonary parenchymal involvement in chronic lympho-
cytic leukemia is characterized by lymphocytic infiltrates
in the peribronchial and perivascular interstitium, as well
as in the alveolar walls and septa [4]. These changes are
reported to occur in approximately one-third of patients
with chronic lymphocytic leukemia [20, 21]. The deve-
lopment of endobronchial infiltration in the course of
chronic lymphocytic leukemia is distinctly uncommon
[22]. The endobronchial infiltrates can be considered as
the extension of a peribronchial infiltrative process [22].
Endobronchial infiltrates may occur several years after the
diagnosis of chronic lymphocytic leukemia [22]. In these
rare cases submucosal infiltration by malignant lympho-
cytes may lead to endobronchial narrowing [22]. Multiple
foci of endobronchial leukemic infiltrates may cause
atelectasis [4, 20]. Massive peribronchial lymphadeno-
pathy may be present [20]. In the course of chronic
lymphocytic leukemia the histopathologic examination
of endobronchial mass may demonstrate the presence of
anaplastic large cell lymphoma consistent with Richter’s
transformation [4].
The treatment of endobronchial lesions caused by
infiltration by malignant lymphocytes in the course of
chronic lymphocytic leukemia can be effectively palliated
with local irradiation and steroid therapy [22]. A reso-
lution of the endobronchial mass developing in the course
of Richter’s transformation after bronchoscopic Nd-YAG
laser therapy while the patient underwent chemotherapy
has been described [4].
It has to be noted that in patients with chronic
lymphocytic leukemia there is an increased risk of develo-
ping secondary malignancies, including lung cancer,
laryngeal cancer, melanoma, and Kaposi’s sarcoma [23].
Endobronchial Kaposi’s sarcoma
Kaposi’s sarcoma is a recognized complication of solid
organ transplantation [5, 24]. It is also the most common
malignancy occurring in AIDS patients [6, 25]. In AIDS
patients infected with human herpes virus-8 (called
Kaposi’s sarcoma associated virus) pulmonary Kaposi’s
sarcoma usually develops as an extensive mucocutaneous
disease [5, 26]. In some cases, however, solitary endo-
bronchial Kaposi’s sarcoma develops without cutaneous
involvement [6, 27]. CT findings may be completely
normal despite endobronchial isolated Kaposi’s sarcoma
[6] or may reveal coexisting typical signs, such as tumor
masses, numerous nodules, bronchovascular pathway
thickening, and bilateral pleural effusions [28, 29].
Early recognition of pulmonary Kaposi’s sarcoma is
essential, because chemotherapy, radiation therapy, and
highly active retroviral therapy may provide palliation or
improve survival in AIDS patients [25, 26], while the
497
modification of immunosuppressive therapy in organ
transplant patients may bring on disease remission [5].
Pulmonary melanoma
Primary pulmonary endobronchial malignant melanoma
is an extremely rare tumor [30, 31]. More frequent are
pulmonary melanoma metastases, including their
endobronchial form [8, 32, 33]. Melanoma in the lung
probably arises from residual melanoblasts [7]. Endo-
bronchial melanoma has a tendency to present as
a central polypoid growth [30, 31]. It may closely resemble
carcinoid tumors or poorly differentiated non-small-cell
carcinoma of the lung [31]. In the biopsy samples melanin
may be present on hematoxylin and eosin staining [31].
Immunohistochemical staining may help in establishing
the diagnosis of primary pulmonary endobronchial
melanoma [30, 31].
Endobronchial metastases
Endobronchial metastases from extrathoracic primary
malignancies usually represent a late manifestation of
the primary disease with generally poor prognosis [34]. In
a group of over 1000 patients with histologically verified
endobronchial lesions, endobronchial metastases made
up some 1.5% of cases [35]. However, in some large series
of patients with proven pulmonary metastases this type of
lesion has been found in up to 46% [36] – 50,4% [37] of
cases.
There are four developmental modes of endobron-
chial metastases from non-pulmonary neoplasms [38].
These are: direct metastasis to the bronchus, bronchial
invasion by mediastinal or hilar lymph node metastasis,
peripheral lesion extending along the proximal bronchus,
and – rarely – bronchial invasion by a parenchymal lesion
[38].
Endobronchial metastatic tumors may present as
polypoid or nodular lesions covered with necrotic material
[36]. In case of direct extension to the bronchi from
adjacent metastatic foci submucosal swelling with an
irregular margin and narrowing of the bronchial lumen
can be seen [36].
Symptoms and radiological/endoscopic signs in
endobronchial metastatic carcinoma are indistinguishable
from those of primary lung cancer [11, 34]. The most
common clinical manifestations include coughing, haemo-
ptysis, dyspnea, and recurrent pulmonary infections; the
course of the disease may also be asymptomatic [8].
A common radiologic finding in CT in case of endo-
bronchial metastasis is an atelectasis [39, 40]. CT, and
especially spiral CT, may help in the identification of
endobronchial lesions and occasionally reveal the other
metastatic lesions: pulmonary nodules, lymphangitis
carcinomatosa, and pleural involvement [41].
Immunohistochemical techniques using different
antibodies may help to find the primary tumor which has
metastasized into the lung [42] – thyroid or prostate
carcinomas, melanomas, sarcomas, lymphomas – all of
those are known to form endobronchial metastatic masses
– can be reliably differentiated with immunohistochemical
methods [42].
In different series of patients with endobronchial
metastatic lesions the most frequent primary tumors are:
thyroid, head-neck and breast carcinoma [37], colon,
rectal, breast, uterine carcinoma and osteosarcoma [38];
colon, breast and renal carcinoma [34]; colon, rectal and
renal carcinoma [11]; breast and colon carcinoma [8, 36].
In some cases endobronchial metastatic lesions may
develop in the course of melanoma [8, 32, 33], basal cell
carcinoma, bladder carcinoma, gastric carcinoma [34, 43],
pheochromocytoma [44], and prostatic carcinoma [45].
In some cases of endobronchial metastases causing
dyspnea and/or hemoptysis, photodynamic therapy may
help in alleviating the symptoms, although the mortality is
high [46].
Conclusion
Rare primary and secondary malignancies other than
small cell lung cancer or non-small cell lung cancer have
to be included in the differential diagnosis of endo-
bronchial neoplastic lesions.
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